Lenox Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Lenox Wealth Management's PFE Position: Q2 2020 in Review
Lenox Wealth Management increased its Pfizer (PFE) stake by 23% in Q2 2020, buying an estimated $13.4K and bringing the position to 2,139 shares worth $66K. The position accounts for 0.02% of the portfolio, ranked #227.
Lenox Wealth Management first reported a position in PFE in Q4 2013 and has held it in 27 quarters since. The position peaked at $81K in Q4 2016. 2,441 funds tracked by Wall St. Rank hold PFE as of Q2 2020.
- Lenox Wealth Management held 2,139 shares of Pfizer worth $66K as of Q2 2020.
- Lenox Wealth Management bought 393 Pfizer shares in Q2 2020, an estimated $13.4K.
- Pfizer made up 0.02% of Lenox Wealth Management's portfolio in Q2 2020, its #227 holding.
- Lenox Wealth Management first reported a position in Pfizer in Q4 2013 and has held it in 27 quarters since.
- Lenox Wealth Management's Pfizer position peaked at $81K in Q4 2016.
- 2,441 funds tracked by Wall St. Rank held Pfizer as of Q2 2020.
Based on Lenox Wealth Management's 13F filing for Q2 2020, filed 28 Jul 2020.